Medicines Co. | Key People and Executives
Clive A. Meanwell
Chief Executive Officer & Director
Geno J. Germano
Independent Director
Sarah J. Schlesinger
Independent Director
Paris Panayiotopoulos
Independent Director
Alexander John Denner
Independent Director
John C. Kelly
Independent Director
Clive A. Meanwell
Chief Executive Officer & Director
Christopher Visioli
Chief Financial Officer & Treasurer
Christopher T. Cox
Chief Corporate Development Officer & EVP
Michael N. Dudley
Senior Vice President & Head-Health Science
Robert Werner
Vice President-Value & Market Access
Stephanie Plent
EVP & Head-Global Health Economics
Bruce R. Rosengard
Vice President-New Business Ventures
Krishna Gorti
Vice President-Investor Relations
Nancye Green
Executive Vice President-Global Communications
Stephen M. Rodin
Deputy General Counsel
Loretta M. Itri
EVP-Global Health Science & Regulatory Affairs
Geno J. Germano
Independent Director
Sarah J. Schlesinger
Independent Director
Paris Panayiotopoulos
Independent Director
Alexander John Denner
Independent Director
John C. Kelly
Independent Director
| Address |
8 Sylvan Way
Parsippany New Jersey 07054
United States
|
|
Employees
|
- |
| Website |
http://www.themedicinescompany.com |
| Updated |
07/08/2019 |
| The Medicines Co. operates as a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. |
